How to Evaluate a Cancer Treatment Claim Online

Patient guide · Last updated November 6, 2026

If you have cancer, or love someone who does, the internet offers a thousand promised ways out. Some are honest hope; many are marketing. This guide gives you a repeatable method — the same one we use in our own evidence reviews — for separating the two. It takes about twenty minutes per claim.

Step 1: Follow the money

Before reading a word of content, look for the transaction. Does the site sell the product, an ebook, a consultation, a supplement bundle, or a membership? Does every article end in a purchase link? Is there an “About” page naming real people? Revenue is not automatically disqualifying — we run ads ourselves — but the pattern matters. Claims bundled with an exclusive purchase channel deserve extra skepticism, because the seller profits from your belief rather than from your outcome.

Step 2: Identify the evidence layer

Every medical claim sits on one of these layers, and the layer determines what can honestly be said:

• Lab study: a compound killed cancer cells in a dish. This is a reason for research, not a reason for hope.
• Animal study: it worked in mice or rats. Frequently promising; frequently not translated.
• Case report: one or a few patients improved while taking it. Confounded by everything else they were doing.
• Randomized controlled trial: patients were randomly assigned to receive it or not, and the group that did fared better. The only layer that can establish cause and effect.

Marketing language loves to blur these layers — “studies show” doing duty for a single petri-dish paper. Whenever you see a citation, click it and place it on the ladder above.

Step 3: Search the trial registry

ClinicalTrials.gov is the U.S. registry of human trials, free and searchable. Search the compound’s name and read what comes back: completed trials with results are the gold standard; a “recruiting” listing means evidence is still being gathered; an empty search means no one has tested the claim in humans. This single step resolves most internet controversies in minutes. For fenbendazole, for example, it reveals that the human cancer trials popular posts imply simply do not exist — which is why our review spends its time on lab studies and case reports instead.

Step 4: Check the regulators and major societies

Read what the FDA, the American Cancer Society, and the relevant professional societies (like ASCO) have published on the claim. These bodies are imperfect but public, sourced, and accountable — and when several of them independently publish aligned warnings, that is a signal no testimonial can outweigh. Their patient-facing explainers are written in plain language and take ten minutes to read.

Step 5: Write down five questions for your oncologist

Bringing a printed forum post usually gets a shrug; bringing specific questions gets a real conversation. Good ones:

1. “Has this compound been studied in trials for my cancer type? What did they find?”
2. “Could it interact with my current regimen — especially my liver or blood counts?”
3. “If I took it anyway, what would you monitor, and how often?”
4. “Are there legitimate clinical trials of repurposed drugs I could enroll in?”
5. “What is the evidence behind the supplements in this protocol?”

The answers become your decision, made with the person holding your full chart — not with a stranger selling capsules.

Red flags checklist

• Publishes exact doses and schedules for drugs not approved for that use in humans.
• “They don’t want you to know” framing — conspiracy as a substitute for citations.
• Testimonials presented as proof, especially collections where every story succeeds.
• “Proven in Europe/Asia” without a link to an actual trial registry entry.
• The protocol, the source, and the seller are the same website.
• Warnings dismissed as Pharma propaganda rather than addressed with evidence.

Where to read trustworthy information

For treatment facts: the National Cancer Institute and the American Cancer Society. For trials: ClinicalTrials.gov. For professional guidance: ASCO. For systematic reviews of evidence: Cochrane Library. And for the specific story that brings most readers here, our own documented timeline and safety review.

A worked example: the five steps applied to fenbendazole

To see the method in action, run it on the claim that brings most readers here. Step 1: much of the content ranking for this topic ends in supplement purchases or paid “protocol guides.” Flag raised. Step 2: the best-available evidence sits at the lab and case-report layers — a 2018 cell-and-mouse study and a few published case series, detailed in our evidence review. Step 3: a ClinicalTrials.gov search returns no completed human cancer trial — the decisive finding. Step 4: ASCO’s 2026 notice, the American Cancer Society’s explainer, and the FDA’s animal-safety letter all point the same direction, with the FDA documenting harm from extra-label use. Step 5: the five questions above, brought to your oncologist. Twenty minutes of structured checking converted a viral anecdote into a precisely characterized state of knowledge: biologically interesting, clinically unproven, regulatorily warned, and genuinely risky to self-administer. Run any claim you encounter through the same sequence before acting on it — or before you recommend it to someone you love.

Sources